Note: This article may contain commentary reflecting the author's opinion.

A new peer-reviewed study from Brazil has found that Ivermectin, an anti-patristic drug that some like Joe Rogan advocated for to treat Covid-19, has been found to reduce the risk of dying from the coronavirus by 92 percent.

The study was conducted in Itajai, Brazil by lávio A. Cadegiani, MD, MSc, Ph.D., who is an expert on clinical endocrinology, according to Blaze News.

“Among 223,128 subjects from the city of Itajaí, 159,560 were 18 years old or up and were not infected by COVID-19 until July 7, 2020, from which 45,716 (28.7%) did not use and 113,844 (71.3%) used ivermectin,” the study explained. “Among ivermectin users, 33,971 (29.8%) used irregularly (up to 60 mg) and 8,325 (7.3%) used regularly (more than 180 mg). The remaining 71,548 participants were not included in the analysis.”

Amongst the subjects who used Ivermectin before being infected, they experienced reductions in both death and hospitalizations: “The hospitalization rate was reduced by 100% in regular users compared to both irregular users and non-users.”

92 percent of those who took Ivermectin regularly saw a 92 percent reduction in their death risk compared to non-users and an 84 percent death risk reduction compared to irregular users.


Do you think Trump should be arrested?*
This poll gives you free access to our premium politics newsletter. Unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

“Mortality rate was 92% lower in regular users than non-users and 84% lower than irregular users, while irregular users had a 37% lower mortality rate reduction than non-users,” the study stated. “Risk of dying from COVID-19 was 86% lower among regular users than non-users, and 72% lower than irregular users, while irregular users had a 51% reduction compared to non-users.”

“Non-use of ivermectin was associated with a 12.5-fold increase in mortality rate and a seven-fold increased risk of dying from COVID-19 compared to the regular use of ivermectin,” the study concluded. “This dose-response efficacy reinforces the prophylactic effects of ivermectin against COVID-19.”

Following the publication of the study, Cadegiani wrote on Twitter that the data is “hard to be refuted.”

“An observational study with the size and level of analysis as ours is hardly achieved and infeasible to be conducted as a randomized clinical trial,” wrote the doctor. “Conclusions are hard to be refuted. Data is data, regardless of your beliefs.”

This study provides considerable evidence that Ivermectin, which was maligned by the medical establishment and leftist activists during the pandemic, reduces risks of coronavirus infection and Cadegiani is right when he says, “Data is data, regardless of your beliefs.”

You Can Follow Sterling on Twitter Here

Note: According to Health Feedback, the study referenced in the article above, “analyzed data in such a way that led people who developed COVID-19 to be excluded from the group of regular ivermectin users, regardless of their actual ivermectin use. Therefore, COVID-19 patients are underrepresented in the group of regular ivermectin users, making this group appear to have a lower risk of COVID-19 death compared to irregular users or non-users.”